Abstract The complex pathophysiology of traumatic brain injury (TBI) involves not only the primary mechanical event but also secondary insults such as hypotension, hypoxia, raised intracranial pressure and changes in cerebral blood flow and metabolism. It is increasingly evident that these initial insults as well as transient events and treatments during the early injury phase can impact hypothalamic-pituitary function both acutely and chronically after injury. In turn, untreated pituitary hormonal dysfunction itself can further hinder recovery from brain injury. Secondary adrenal insufficiency, although typically reversible, occurs in up to 50% of intubated TBI victims and is associated with lower systemic blood pressure.
of life problems, the most common being memory and concentration deficits, depression, anxiety, fatigue and loss of emotional well being [4] [5] [6] [7] [8] .
The pathophysiology of TBI is admittedly complex and in many ways still poorly understood largely due to the fact that there is such a wide spectrum of injury severity, injury mechanisms and brain injury patterns across all age ranges. Nonetheless, our clinical appreciation of the pathophysiology of TBI and how to favorably alter it has grown dramatically over the last several decades. The modern therapeutic paradigm for moderate and severe TBI victims is centered on the concepts of rapidly treating the primary brain injury, correcting or avoiding secondary brain insults and optimizing cerebral blood flow and metabolism [9] [10] [11] [12] [13] . From a practical standpoint, acute interventions include emergency evacuation of intra-cranial hematomas to reduce mass effect and prevent herniation, avoidance or correction of systemic hypotension, hypoxia, hyperthermia and seizures, and aggressive treatment of low cerebral perfusion pressure and high intracranial pressure [9, 12, 13] . Long-term interventions include cognitive rehabilitation as well as occupational and physical therapy [14, 15] . Neuro-behavioral recovery from moderate (GCS 9-13) and severe (GCS 3-8) TBI is an often slow and incomplete process. Most patients make dramatic gains in recovery between 3 and 6 months post-injury and then tend to plateau over the next several months with few further gains typically seen after 12 months post-injury [9, 12, 13] . Based on multiple studies over the last two decades, the factors most strongly associated with a poor long-term outcome after moderate and severe TBI include advanced age, and the acute injury factors of non-reactive pupils, systemic hypotension, hypoxia, persistently raised intracranial pressure and adverse acute computed tomography (CT) findings such as loss of cisterns, midline shift and acute subdural hematomas [9, 12, 13] .
It is only within the last decade that the concept of routine pituitary hormonal monitoring and treatment has been considered in this therapeutic paradigm [16] [17] [18] . Herein we discuss the pathophysiological underpinnings of this new focus on neuro-endocrine dysfunction. The importance of gaining a clearer understanding of this facet of TBI is particularly relevant given that numerous clinical trials of neuroprotective agents in TBI patients over the last two decades have all failed [19] and the need for effective therapies persists.
The growing awareness of TBI-induced hypopituitarsim
Although it has been known for almost a century that TBI can result in pituitary failure, it has only been in the last decade that we have gained a better understanding of how often and under what conditions hypothalamic-pituitary axis damage occurs after TBI. Similarly, it is only recently that a clear association has emerged between post-TBI neuro-endocrine dysfunction and neurobehavioral and quality of life impairments. Pituitary failure after TBI was first reported in 1918 by Cyran [20] . Since the 1970s, multiple case reports have been published documenting both anterior [21] [22] [23] [24] [25] and posterior pituitary dysfunction [26, 27] . Literature reviews demonstrating frequent hypopituitarism after TBI brought more attention to the subject [28, 29] , resulting in numerous prospective cohort studies documenting new pituitary failure. Most studies assessing human pituitary function within the first year of moderate or severe TBI show that there is typically some reversibility of hypopituitarism between 3 months and 6-12 months of injury but that new hormonal deficits may also develop more than 3 months after injury [5, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Collectively, these studies indicate that by 6-12 months post-injury, 25-40% of moderate and severe TBI patients will develop chronic hypopituitarism with the somatotroph and gonadotroph axes being most commonly affected [5, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . New chronic somatotroph failure (growth hormone deficiency) averages 15-18% of patients, followed by hypogonadism with rates averaging 14%. In contrast, new corticotroph, thyrotroph and posterior pituitary deficiencies (permanent diabetes insipidus) are less common with rates averaging 8%, 5% and 2%, respectively [30, 32, 33, [38] [39] [40] [41] [42] [43] [44] [45] . These rates of long-term post-TBI pituitary failure are fairly consistent across multiple studies and indicate a greater resilience of the adrenal, thyroid and posterior pituitary axes and a relative vulnerability of the somatotroph and gonadotroph axes. As discussed below, this hierarchy of hormonal loss appears to be relevant to the pathophysiology of post-TBI hypopituitarism.
Probably the most important aspect of TBI-induced hypopituitarism, even if the pathophysiology is incompletely understood, is the potential impact on brain recovery. It is generally accepted that the most common neurobehavioral and quality of life complaints affecting TBI survivors are memory and concentration deficits, depression, anxiety, fatigue and loss of emotional well being [4] [5] [6] [7] . These complaints are similar to those of patients suffering from chronic hypopituitarism including growth hormone (GH) deficiency, hypogonadism, adrenal insufficiency and hypothyroidism. It has thus been hypothesized that in a substantial minority of patients, untreated endocrinopathy, particularly growth hormone deficiency, may be a major factor in ongoing neurobehavioral and quality of life impairments in the chronic phase after injury [5, 31, 46] .
Regarding the acute and subacute recovery phase of TBI, most of the pituitary hormones have been shown to have important cerebral effects that impact not only brain development, but also allow normal brain function and are integral for effective brain repair and recovery. For example, it is now clear that there are both GH and insulinlike growth factor (IGF-1) receptors widely present in the brain. While GH has been shown to be directly involved in vascular reactivity, vascular tone and CNS repair processes after hypoxic injury, IGF-1 appears to be an important factor in myelination, re-myelination, prevention of demyelination and protection of oligodendrocytes from tumor necrosis factor-a induced apoptosis [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . Therefore, acute hormonal deficiencies may have deleterious impact on the early neuroprotective and repair processes following TBI.
Pathophysiology of hypopitutarism after TBI

Overview
Although the etiology of post-TBI pituitary hormonal dysfunction remains incompletely understood, existing evidence suggests that multiple factors are relevant including: (1) the primary brain injury event itself, (2) secondary insults such as hypotension and hypoxia, (3) the transient stress of critical illness, and (4) transient medication effects. It is also possible that some patients harbor a pre-existing susceptibility to TBI-induced hypopituitarism. It is likely that these factors individually and in varying combinations determine which hormonal axes are affected, the severity of abnormality and whether such deficits are reversible or permanent. Below we discuss the evidence for and against each of these possible factors in the acute and chronic pathophysiology of TBI.
Pituitary gland vascular anatomy and blood supply
The pituitary gland, typically weighing less than one gram and measuring approximately 8 mm by 10 mm, is located within the sella turcica in the skull base. It is separated from the suprasellar cistern by the diaphragma sella and is tethered to the hypopthalamus by the infundibulum which inserts on its superior surface [57] . The adenohypophysis and neurohypophysis receive their blood supply primarily from the internal carotid arteries. The long hypophyseal portal vessels arise from branches of the internal carotid artery (primarily the superior hypophyseal arteries) and anterior Circle of Willis above the diaphragma sella, travel down the infundibulum and provide the anterior pituitary gland with 70-90% of its blood supply (Fig. 1) . The short hypophyseal portal vessels arise from branches of the intracavernous internal carotid artery, the inferior hypophyseal arteries, which enter the sella from below the diaphragma sella and supply the anterior gland with less than 30% of its vascular supply, predominantly in the medial portion of the gland including the pars intermedia [58] [59] [60] . End-arteries also supply small but variable portions of the anterior lobe [60] .
Primary and secondary brain injury
Given the pituitary glands confinement within the bony sella and overlying diaphragma sella, and its tethering to the hypothalamus by the infundibulum, it has been hypothesized that the anterior and posterior gland may be susceptible to mechanical trauma at the moment of impact.
Fractures through the skull base and sella turcica as well as rotational and shearing injuries of the brain stem and hypothalamic-pituitary axis may directly injure the gland, infundibulum and/or hypothalamus. Subsequent hemorrhage into the sella turcica or gland itself can further compromise pituitary integrity [10, 39, 59, [61] [62] [63] . Additional secondary insults from hypotension, hypoxia, anemia and brain swelling that often accompany major trauma, may lead to an ischemic injury to the pituitary gland similar to that seen in Sheehan's post-partum pituitary necrosis [64] . Because the long portal vessels arise within the subarachnoid space and pass through the diaphragma sella, these vessels and the pituitary stalk are thought to be particularly vulnerable to mechanical trauma, intracranial hypertension, low cerebral blood flow and brain swelling (Fig. 1) . This concept was presented over 40 years ago by Daniel et al. [62] who first showed traumatic infarction of the anterior pituitary gland (Fig. 2) . Further support of this pathophysiological concept comes from autopsy studies of fatal head injuries performed in the 1960s and 1970s in which up to one-third of victims sustained anterior pituitary gland necrosis [58, 61-63, 65, 66] . In over 200 subjects studied in two studies by Ceballos [61] and Kornblum and Fisher [63] 59% of patients had capsular hemorrhage around the pituitary gland, 31% had posterior lobe hemorrhage, 3% had stalk necrosis and one had a stalk laceration. Most striking was the finding of anterior lobe necrosis in 22% of subjects. In the study by Kornblum and Fisher [63] , of subjects surviving at least 12 h, anterior lobe necrosis was seen in 35%. In these cases, the infarction pattern was in the blood supply pattern of the long hypophyseal portal veins while tissue in the vascular territory of the short portal veins survived. Crompton also published an autopsy series of 106 TBI victims and documented ischemic or hemorrhagic hypothalamic lesions in 42% and pituitary lesions in 28% of specimens [66] . It is notable that these studies were focused on fatal injury victims who likely had periods of severe hypotension, hypoxemia and/or ischemia due to herniation and high intracranial pressure leading to their demise. Therefore, it is unclear that these concepts can be generalized to non-fatal TBI to explain chronic hypopituitarism in survivors. Few studies of post-traumatic hypopituitarism have adequately addressed the risk factors and underlying pathophysiology that leads to insufficiency. However, there are two strong arguments that support this vascular hypothesis of pituitary injury.
First, recent magnetic resonance imaging studies of the pituitary have demonstrated pathological changes consistent with vascular injury. In the acute phase, the pituitary glands of TBI patients are significantly enlarged as compared with normal healthy control subjects and many also demonstrate other abnormalities such as hemorrhage, infarction, signal abnormalities and/or partial stalk transsection [67] . In the chronic phase, patients often demonstrate pituitary volume loss or empty sella, followed by abnormal pituitary gland signal heterogeneity, perfusion deficits and/or lack of posterior pituitary signal [68] . As shown by Schneider et al., these abnormalities occurred in 80% of patients with hypopituitarism versus only 29% of those without hypopituitarism (P = 0.032).
The second line of evidence that supports a vascular etiology of chronic hypopituitarism is related to the pattern of hormonal loss. As noted above, the somatotroph and gonadotroph axes have consistently been found to be the most susceptible to dysfunction following TBI [31, 33, 36, 38, 39, 43, 44] . The somatotrophs are located primarily in the lateral wings of the anterior pituitary and the gonadotrophs are scattered throughout the pars distalis and are the major cell group in the pars tuberalis [69] . This cellular distribution is consistent with the area of irrigation of the long hypophyseal portal vessels. An infarction of this lateral and peripheral region of the gland will mostly affect somatotrophs and gonadotrophs. The corticotrophs, found predominantly in the central mucoid wedge and pars intermedia, and the thyrotrophs, tending to cluster in the anteromedial portion of the gland, are thus in the less susceptible short hypophyseal portal territory.
Most prior studies have failed to show a definitive relationship between injury-related factors and the development of hypopituitarism [32, 39-41, 44, 45, 70-72] . However, more recently, Klose et al. have found severe TBI and increased intracranial pressure to be predictive of hypopituitarism [37] . Schneider et al. have also found other markers of severe injury, including diffuse axonal injury, basilar skull fractures and older age to be predictive of chronic hypopituitarism [36] . Additionally, our recently published study of 70 TBI patients with long-term follow-up suggests that the degree of brain injury as defined by acute CT (presence of diffuse brain swelling and evacuated intracerebral hematoma or multiple contusions, in particular) is the strongest predictor of subsequent hypopituitarism [43] . All patients with major chronic hormonal deficits in our series had severe parenchymal brain injury including 87% with diffuse brain swelling. Although the degree of brain injury as seen on CT appears to be a key risk factor for chronic hypopituitarism, as to how this parenchymal brain injury ultimately results in chronic pituitary dysfunction remains unclear. Interestingly, in our study, no association was seen between long-term hypopituitarism and acute hypotension, hypoxia, anemia or Fig. 1 Illustration demonstrating the anatomy and blood supply of the hypothalamic-pituitary axis. Note that the superior hypophyseal artery and long hypophyseal portal vessels arise above the diaphragma sella which may make them vulnerable to intracranial injury including shearing forces as well as compression by raised intracranial pressure, brain swelling, and brain shift. (Abbreviations: cICA, cavernous internal carotid artery; DS, diaphragma sella; I, infundibulum; IHA, inferior hypophyseal artery; LHV, long hypophyseal portal vessels; OC, optic chiasm; P, pituitary gland; SHA, superior hypophyseal artery; SHV, short hypophyseal portal vessels) intracranial hypertension. However, in our prior study of acute adrenal insufficiency which occurred in 50% of intubated TBI subjects within 10 days of injury, the ischemiarelated factors of hypotension, hypoxia and anemia did correlate with development of transient acute adrenal insufficiency [35] . This reversibility of acute adrenal insufficiency and the fact that chronic adrenal insufficiency is so uncommon suggests that other factors (as discussed below) may be relevant in the acute setting. Finally, it is also important to note that a severe injury is not necessarily a prerequisite for development of chronic pituitary failure. Several studies have demonstrated chronic endocrinopathy after milder TBI [28, 29, 39, 45] . Furthermore, it appears that repeated mild TBI as occurs in contact sports such as boxing, may result in a high rate of pituitary failure, particularly growth hormone deficiency [73] .
Stress of critical illness and medication effects
Few studies have assessed risk factors or the pathophysiology of acute hypopituitarism after TBI. In our study of acute secondary adrenal insufficiency we found that severity of injury, as measured by the injury severity score, younger age, ischemic factors and medication effects all had an impact on acute cortisol and ACTH levels [35] . Although ischemia factors of hypotensions, hypoxia and severe anemia were found to be important, medication effects were significantly more contributory to the development of adrenal insufficiency. [35] . As previously published, the effect of a single dose of etomidate on adrenal function was only seen within the first 24 h of injury. In contrast, the effect of the metabolic suppressive agents high-dose pentobarbital and propofol were more lasting but still reversible and dose-dependent [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] . Those TBI patients with acute adrenal insufficiency who survived, all returned to normal adrenal functioning on chronic follow-up. Therefore, this acute hypopituitarism appeared to be a transient and reversible effect largely related to metabolic suppressive agents or etomidate and did not lead to overt chronic adrenal deficiency. As for the other hormonal axes, recent studies and reviews have demonstrated growing acceptance for the fact that the stress of critical illness has profound effects on the acute functioning of all pituitary hormonal axes. For example decreases in T3 (sick euthyroid syndrome) commonly occurs in critically ill patients. Similarly, abrupt and profound decreases in serum testosterone are uniformly seen in critically ill men [74, [84] [85] [86] [87] [88] [89] [90] [91] . It remains unclear whether these changes are deleterious or adaptive responses to critical illness. The impact of medications such as vasopressors as well the immune response to multiple trauma further complicate this highly dynamic pathophysiological state [89, 92, 93] . Further work in this area is clearly needed.
Conclusions
Acute and chronic pituitary dysfunction is common after moderate and severe TBI and may occur in some instances of mild TBI. This hormonal dysfunction can impact the early and late recovery process, ultimately effecting longterm neurobehavioral function and quality of life. Based on prior autopsy studies of fatal head injuries and imaging studies of TBI survivors, it appears the site of injury leading to pituitary hormonal dysfunction is variable and may include the hypothalamus, infundibulum and pituitary gland itself. Although the mechanism of post-TBI pituitary dysfunction remains incompletely understood, evidence suggests this is a multi-factorial process related to: (1) the primary brain injury event itself; (2) secondary insults such as hypotension, hypoxia and raised intracranial pressure; (3) the transient stress of critical illness; and (4) transient medication effects. It is likely that these factors individually and in varying combinations determine which hormonal axes are affected, the severity of abnormality and whether such deficits are reversible or permanent. Further experimental and clinical studies are needed to better delineate the pathophysiology and impact of neuro-endocrine dysfunction after TBI, which in turn will hopefully lead to more effective hormonally-based treatments.
